Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:UMRX

Cogent Biosciences (UMRX) Stock Price, News & Analysis

Cogent Biosciences logo

About Cogent Biosciences Stock (NASDAQ:UMRX)

Advanced Chart

Key Stats

Today's Range
$11.81
$12.44
50-Day Range
$2.35
$13.01
52-Week Range
$0.29
$3.72
Volume
1.15 million shs
Average Volume
1.22 million shs
Market Capitalization
$514.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UMRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter.

UMRX Stock News Headlines

Get This Stock Now
This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.tc pixel
See More Headlines

UMRX Stock Analysis - Frequently Asked Questions

Cogent Biosciences, Inc. (NASDAQ:UMRX) issued its quarterly earnings results on Tuesday, August, 11th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.03. The firm earned $0.53 million during the quarter. Cogent Biosciences had a negative trailing twelve-month return on equity of 87.78% and a negative net margin of 96.84%.

Cogent Biosciences (UMRX) raised $75 million in an initial public offering (IPO) on Thursday, March 29th 2018. The company issued 5,800,000 shares at $12.00-$14.00 per share. Morgan Stanley and Cowen acted as the underwriters for the IPO and SunTrust Robinson Humphrey and Wedbush Securities were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cogent Biosciences investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/11/2020
Today
8/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:UMRX
CIK
1622229
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.83 million
Net Margins
-96.84%
Pretax Margin
N/A
Return on Equity
-87.78%
Return on Assets
-52.14%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
2.90
Quick Ratio
2.90

Sales & Book Value

Annual Sales
$22.50 million
Price / Sales
22.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.04 per share
Price / Book
11.65

Miscellaneous

Outstanding Shares
42,469,000
Free Float
N/A
Market Cap
$514.72 million
Optionable
Not Optionable
Beta
3.93
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:UMRX) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners